MG
Meditor Group Portfolio holdings
AUM
$48.1M
This Quarter Return
-7.33%
1 Year Return
+38.67%
3 Year Return
+41.15%
5 Year Return
+72.2%
10 Year Return
+1,065.64%
AUM
$465M
AUM Growth
+$465M
(-9.1%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 95.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Exelixis
EXEL
$10.1B
| $283M | 60.81% |
15,966,038
| – | – |
|
2
Esperion Therapeutics
ESPR
$448M
| $117M | 25.08% |
2,629,835
| – | – |
|
3
Alkermes
ALKS
$4.78B
| $43.7M | 9.4% |
1,030,639
| – | – |
|
4
WisdomTree India Earnings Fund ETF
EPI
$2.86B
| $9.64M | 2.07% |
400,000
| – | – |
|
5
iShares MSCI India ETF
INDA
$9.17B
| $9.42M | 2.02% |
290,000
| – | – |
|
6
Celldex Therapeutics
CLDX
$1.47B
| $2.85M | 0.61% |
6,312,700
| – | – |
|